The University of California, Los Angeles invites applications and nominations for a nationally and internationally recognized leader in academia, industry, or government to join the faculty of the David Geffen School of Medicine (DGSOM) as Chair of the Department of Molecular and Medical Pharmacology (DMMP). As a preeminent researcher, scholar and leader, the candidate will also be considered for an endowed chair.

 

The Chair is responsible for advancing the Department’s mission of excellence in education, research, and community engagement through the development of educational programs, cross-disciplinary research and innovation, financial management, staffing, performance growth, faculty recruitment and retention, and the strengthening of community partnerships.  The Chair will continue the tradition of cultivating a scientifically rigorous as well as highly collegial, inclusive, and multidisciplinary environment consistent with the principles of the DGSOM’s Cultural North Star. The Chair reports to the Vice Chancellor for Health Sciences and Dean of the DGSOM.  

 

With 38 faculty members, 78 staff members and many trainees at various levels of training, the Department is ranked highly with a total research portfolio of more than $19 million ($8+ million in NIH funding). The DMMP integrates mathematics, engineering, physical, chemical, biological and medical sciences to understand the biology of disease, develop new molecular diagnostics, and develop new molecular and cellular therapeutics.

 

The Department of Molecular and Medical Pharmacology is a hub of innovation, discovery, and translational impact. With a strong foundation in cutting-edge research and an entrepreneurial spirit, the department has successfully launched six spinoff start-up companies, underscoring its commitment to transforming scientific breakthroughs into real-world applications. A national leader in molecular imaging and probe development, the department continues to pioneer new approaches that advance both diagnostics and targeted therapies. This culture of innovation positions the department at the forefront of precision medicine and next-generation biomedical technologies.

 

Located in a metropolitan setting, UCLA has been ranked as the number one public university in the nation by U.S. News & World Report for the last eight years. UCLA is California's largest university with a diverse student body of 38,000 undergraduate, graduate, and professional students. UCLA is known both for its excellence in research and education with a >$1 billion research portfolio. The DMMP is uniquely poised for transformational cross-disciplinary innovations through partnerships with a multitude of institutes, centers and departments, many of which are in close physical proximity across the unified UCLA campus, and through access to exceptional department resources, including the Crump Preclinical Imaging Technology Center, Crump Cyclotron and Radiochemistry Technology Center, Metabolomics Center, and the Molecular Screening Shared Resource.

 

The ideal candidate is a distinguished leader with an outstanding record of accomplishments in research, education and service, philanthropy, and an aptitude for collaboration and leadership. The successful candidate will combine their academic acumen with excellent communication skills, an inspiring strategic vision, and longstanding dedication to mentorship and the development of scientists. All candidates must hold an advanced degree (PhD, MD or equivalent) and appropriate academic credentials for a tenured faculty appointment at UCLA.

 

The search committee invites confidential inquiries, nominations, or submissions of interest (curriculum vitae, informative personal statement, and response to UCLA’s mission statement:

 

Anne Coleman, MD, PhD and Mike Teitell, MD, PhD (committee co-chairs)

c/o Caitlin Hargadon

Senior Executive Recruitment Consultant

Email: ChairPharmacologySearch@mednet.ucla.edu

Apply: https://recruit.apo.ucla.edu/JPF10562